About Adaptive Biotechnologies Corp.
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated. For more information, please visit adaptivebiotech.com.
|
|
|
501-1,000 employees
View all Adaptive Biotechnologies Corp. employees
|
|
Biotechnology
|
|
1551 Eastlake Ave E. Suite 200, Seattle, WA 98102, US
|
|
2009
|
|
Biotechnology, Research, Diagnostic, Therapeutics
|
Adaptive Biotechnologies Corp. Alternatives
Frequently Asked Questions about Adaptive Biotechnologies Corp.
Delphine Galezowski is the CEO of Adaptive Biotechnologies Corp.. To contact Delphine Galezowski email at [email protected], [email protected] or [email protected].
The decision makers in Adaptive Biotechnologies Corp. are Benjamin Eckert, Chad Robins, Craig Halder, etc. Click to Find Adaptive Biotechnologies Corp. decision makers emails.
Adaptive Biotechnologies Corp. Staff Directory
Search Adaptive Biotechnologies Corp. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
